Aug 13, 2024 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Advanced Enzyme Technologies Limited Q1 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Ronak Saraf, Investor Relations. Thank you, and over to you, sir.
Ronak Saraf - Advanced Enzyme Technologies Ltd - Investor Relations Manager
Good evening, everyone. Welcome to Advanced Enzymes Q1 FY25 earnings conference call. I'm Ronak Saraf, the Manager of Investor Relations here at Advanced Enzymes. We hope you all have gone through our financials, press release and the presentation, which has been posted in our Investor Relations section on our website.
We have with us Mr. Mukund Kabra, Whole-Time Director; Mr. Beni Rauka, Group CFO. Today, the management will discuss the performance and business highlights, update on strategies and respond to any questions that you may have. As is usual, for ease of discussion, we will look at the consolidated financials.
Before we proceed, I would like to draw your
Q1 2025 Advanced Enzyme Technologies Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot